Cargando…

Impact of Body Mass Index on Survival Outcome in Patients with Newly Diagnosed Glioblastoma: A Retrospective Single-Center Study

INTRODUCTION: The impact of obesity on survival outcomes in patients with glioblastoma (GBM) has not been well reported and the results for patients are currently unclear. We investigated the effect of obesity on survival outcomes in patients with newly diagnosed GBM. METHODS: Using electronic medic...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cha, Jun-Yong, Park, Jae-Sung, Hong, Yong-Kil, Jeun, Sin-Soo, Ahn, Stephen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869148/ https://www.ncbi.nlm.nih.gov/pubmed/33543653 http://dx.doi.org/10.1177/1534735421991233

Ejemplares similares

Effect of Cumulative Dexamethasone Dose during Concomitant Chemoradiation on Lymphopenia in Patients with Newly Diagnosed Glioblastoma
por: Lee, Changik, et al.
Publicado: (2020)

Extreme body mass index and survival in newly diagnosed multiple myeloma patients
por: Shah, Urvi A., et al.
Publicado: (2023)

Body Mass Index and Overall Survival of Patients with Newly Diagnosed Multiple Myeloma
por: Wang, Bei, et al.
Publicado: (2022)

Cytomegalovirus-Specific Immunotherapy for Glioblastoma Treatments
por: Ahn, Jaehyun, et al.
Publicado: (2022)

Survival with dacarbazine and fotemustine in newly diagnosed glioblastoma multiforme
por: Fazeny-Dörner, B, et al.
Publicado: (2003)

Cilengitide in newly diagnosed glioblastoma: biomarker expression and outcome
por: Weller, Michael, et al.
Publicado: (2016)

HLA polymorphisms and risk of glioblastoma in Koreans
por: Choi, Sang-Soo, et al.
Publicado: (2021)

Polymorphisms of Killer Ig-like Receptors and the Risk of Glioblastoma
por: Choi, Haeyoun, et al.
Publicado: (2023)

Compassionate use of recombinant human IL‐7‐hyFc as a salvage treatment for restoring lymphopenia in patients with recurrent glioblastoma
por: Ahn, Stephen, et al.
Publicado: (2022)

Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients
por: Joo, Jin-Deok, et al.
Publicado: (2012)

Avelumab in newly diagnosed glioblastoma
por: Jacques, Francois H, et al.
Publicado: (2021)

Clinical Characteristics of People with Newly Diagnosed Type 2 Diabetes between 2015 and 2016: Difference by Age and Body Mass Index
por: Ha, Kyoung Hwa, et al.
Publicado: (2018)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017)

Association of body mass index with outcomes in patients with newly diagnosed atrial fibrillation: GARFIELD-AF
por: Camm, Christian Fielder, et al.
Publicado: (2022)

Survival impact of delaying postoperative chemoradiotherapy in newly-diagnosed glioblastoma patients
por: Zhang, Maochen, et al.
Publicado: (2020)

Advances in the treatment of newly diagnosed glioblastoma
por: Theeler, Brett J., et al.
Publicado: (2015)

A Review of Newly Diagnosed Glioblastoma
por: Oronsky, Bryan, et al.
Publicado: (2021)

Newly Diagnosed Glioblastoma in Elderly Patients
por: Yuen, Carlen A., et al.
Publicado: (2022)

The effect of body mass index at diagnosis on clinical outcome in children with newly diagnosed acute lymphoblastic leukemia
por: Eissa, H M, et al.
Publicado: (2017)

Performance of newly developed body mass index cut-off for diagnosing obesity among Ethiopian adults
por: Sinaga, Makeda, et al.
Publicado: (2019)

Body mass index-associated responses to an ABVD-like regimen in newly-diagnosed patients with Hodgkin lymphoma
por: Hu, Min, et al.
Publicado: (2023)

The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients
por: Poulsen, Hans Skovgaard, et al.
Publicado: (2014)

Impact of time to initiation of radiotherapy on survival after resection of newly diagnosed glioblastoma
por: Katsigiannis, Sotirios, et al.
Publicado: (2019)

A balanced score to predict survival of elderly patients newly diagnosed with glioblastoma
por: Straube, Christoph, et al.
Publicado: (2020)

Cerebrospinal fluid leakage repair of various grades developing during endoscopic transnasal transsphenoidal surgery
por: Lee, Il Hwan, et al.
Publicado: (2021)

Levetiracetam as a sensitizer of concurrent chemoradiotherapy in newly diagnosed glioblastoma: An open‐label phase 2 study
por: Hwang, Kihwan, et al.
Publicado: (2021)

Correlation of HbA(1C) Levels With Body Mass Index in Newly Diagnosed Polycystic Ovary Syndrome
por: Bala, Manju, et al.
Publicado: (2017)

Association between body mass index at diagnosis and outcomes in Chinese children with newly diagnosed acute lymphoblastic leukemia
por: Hu, Wenting, et al.
Publicado: (2022)

Correction: Newly Diagnosed Glioblastoma in Elderly Patients
por: Yuen, Carlen A., et al.
Publicado: (2022)

Interstitial photodynamic therapy for newly diagnosed glioblastoma
por: Quach, Stefanie, et al.
Publicado: (2023)

Extended adjuvant temozolomide in newly diagnosed glioblastoma: A single-center retrospective study
por: Chen, Jie, et al.
Publicado: (2022)

Loss of PTEN Is Not Associated with Poor Survival in Newly Diagnosed Glioblastoma Patients of the Temozolomide Era
por: Carico, Christine, et al.
Publicado: (2012)

Correlational Study of Nonalcoholic Fatty Liver Disease Diagnosed by Ultrasonography with Lipid Profile and Body Mass Index in Adult Nepalese Population
por: Khanal, Umesh P., et al.
Publicado: (2019)

The Effect of Body Mass Index on Survival in Advanced Epithelial Ovarian Cancer
por: Bae, Hyo Sook, et al.
Publicado: (2014)

Clinical feasibility of modified procarbazine and lomustine chemotherapy without vincristine as a salvage treatment for recurrent adult glioma
por: Ahn, Stephen, et al.
Publicado: (2022)

Body mass index and all-cause mortality in patients with newly diagnosed type 2 diabetes mellitus in South Korea: a retrospective cohort study
por: Hong, Jae-Seok, et al.
Publicado: (2022)

Extent of Resection in Newly Diagnosed Glioblastoma: Impact of a Specialized Neuro-Oncology Care Center
por: Haj, Amer, et al.
Publicado: (2017)

Estimated lifetime survival benefit of tumor treating fields and temozolomide for newly diagnosed glioblastoma patients
por: Guzauskas, Gregory F, et al.
Publicado: (2018)

Preoperative Immune-Inflammatory Status of the Patients With Newly-Diagnosed Glioblastoma – Could It Genuinely Predict Their Survival?
por: Serban, Georgiana M, et al.
Publicado: (2023)

Spectroscopic MRI-Based Biomarkers Predict Survival for Newly Diagnosed Glioblastoma in a Clinical Trial
por: Trivedi, Anuradha G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6ioros4ep7n8ni109d320mp2kg